Anti-MUC16 Antibody (Sofituzumab vedotin)
Catalog No.
F1566
Anti-MUC16 Antibody (Sofituzumab vedotin)
Featured Products
Sofituzumab vedotin (DMUC5754A) is an anti-MUC16 Antibody-drug conjugates (ADC), with a protease-cleavable linker. Sofituzumab vedotin can be used in cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
1418200-58-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
3A5, DMUC5754A, RG7458
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q8WXI7
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The drug-to-antibody ratio (DAR) of the Anti-MUC16 Antibody (Sofituzumab vedotin) is 4.3.
MUC16
Please avoid freeze-thaw cycles.